Opportunities for Men

Below is a list of the current opportunites for men.

Male Trials

94158 (1)
The study drug is being developed to investigate a new compound for Rheumatoid Arthritis, which is a Chronic Inflammatory Disease affecting the joints, leading to pain, swelling, functional disability and deformity. | View full details »
97290 (1)
This study is being developed to examine the safety, tolerability and effect on the body of a drug hoped to be used to treat schizophrenia. 153 volunteers have already been tested on the study drug (up to 240mg). | View full details »
85728 (9Rb)
The study drug will involve a new compound being developed for the treatment of Multiple Sclerosis (MS). MS is the leading cause of neurological disability in young adults and is the most common disorder of the central nervous system. | View full details »
86319 (8c) Elderly
A first time in human study investigating a new drug for the treatment of Parkinsons Disease. The study will look at the drugs safety, how it acts on the body and how the body acts on it when administered in healthy young and older men. | View full details »
86319 (8b) Elderly
A first time in human study investigating a new drug for the treatment of Parkinsons Disease. The study will look at the drugs safety, how it acts on the body and how the body acts on it when administered in healthy young and older men. | View full details »
93979 (FULL)
The study is being developed to treat noiceptive pain. This is not a first time in man study, 80 volunteers have been dosed to date. | View full details »
93765 (7b)
The study will involve the use of a new compound being developed for the treatment of pain particularly that associated with inflammatory diseases. | View full details »
90362 (4a)
The study involves a new compound being developed for the treatment of epilepsy | View full details »
86319 (8a) Elderly (FULL)
A first time in human study investigating a new drug for the treatment of Parkinsons Disease. The study will look at the drugs safety, how it acts on the body and how the body acts on it when administered in healthy young and older men. | View full details »
85728 (8b)
The study drug will involve a new compound being developed for the treatment of Multiple Sclerosis (MS). MS is the leading cause of neurological disability in young adults and is the most common disorder of the central nervous system. | View full details »
3001 COPD Screening
PAREXEL are looking for people with lung disease (COPD) to attend a full medical screening at our unit. The results of the medical will be used to see if you might be eligible to join our patient database to be considered for medical trials in the future. | View full details »
85728 (8a)
The study drug will involve a new compound being developed for the treatment of Multiple Sclerosis (MS). MS is the leading cause of neurological disability in young adults and is the most common disorder of the central nervous system. | View full details »

The PAREXEL Clinical Pharmacology Research Unit
Level 7, Northwick Park Hospital, Watford Road, Harrow, Middlesex HA1 3UJ
VOLUNTEER FREEPHONE - 0800 389 8930 | Email: drugtrial@parexel.com